It’s Time to Rethink Heart Failure Research

heart failure patient holding hand to heart
By Nancy Newark, R.N., Executive Director, Project Management, Cardiovascular and Metabolic Diseases, Worldwide Clinical Trials,

  Cardiovascular disease remains the number one killer of men and women in the U.S. While the need for new discovery is high, the reality is that little progress has been made to advance treatments during the past few decades – especially for one of the most serious conditions: heart failure.

Read More

Raise Awareness for Cardiovascular Disease by Taking Part in Wear Red Day

Couple wears red for cardiovascular disease awareness
By Karen Hill, SVP, Project Management, Cardiovascular and Metabolic Diseases,

  The forthcoming National Wear Red Day presents an opportune time to increase public awareness for heart disease, raise money for research, and help keep families together. It can also be the appropriate occasion to introduce or conduct successful cardiovascular research in partnership with a reputable contract research organization.

Read More

Clinical Trials Raise Excitement Ahead of American College of Cardiology 2018 Conference

American College of Cardiology annual meeting
By Toni Bransford, MD, FACC, FASE, Executive Medical Director, Scientific Solutions, Cardiovascular and Metabolic Division, Worldwide Clinical Trials,

  The American College of Cardiology (ACC) annual meeting always promises to be an exciting conference for cardiologists and clinical investigators, particularly because it showcases new and innovative clinical technologies or novel uses of time-worn pharmaceuticals. Taking place March 10-12, this year’s meeting will be no exception. I will be there along with Worldwide’s Nancy Newark, RN, Executive Director of Cardiovascular Project Management, and Karen Hill, Senior Vice President, Global Therapeutic Leader, Cardiometabolic. Read on to learn about the sessions we plan to attend. If you’ll also be at ACC, I would love to connect while you’re in town! Please click here to drop me a note.

Read More

Equity in Cardiovascular Health: Charting the Course for Better Cardiovascular Health in African-American Communities

Cardiovascular Health in African-Americans
By Toni Bransford, MD, FACC, FASE, Executive Medical Director, Scientific Solutions, Cardiovascular and Metabolic Division, Worldwide Clinical Trials,

  In the spirit of Heart Month and Black History Month, which both occur in February in the United States, I was asked to take on the difficult question of equity in cardiovascular health in the African American community. But how does cardiovascular health relate to equity? To look at this, we have to look at equity in health and how it affects heart disease.

Read More

New Hypertension Guidelines: What’s Next for Hypertension Therapy?

Hypertension Guidelines, Cardiovascular Clinical Trial
By Toni Bransford, MD, FACC Executive Medical Director, Scientific Solutions, Cardiovascular and Metabolic Division, Worldwide Clinical Trials and Karen Modesto, MD, Senior Medical Director, Medical and Scientific Affairs, Cardiovascular and Metabolic Division, Worldwide Clinical Trials,

  Heart disease is the No. 1 cause of death in the world and the leading cause of death in the United States, killing about 610,000 people every year–that’s 1 in every 4 deaths, claiming more lives than all forms of cancer combined1, 2. Having high blood pressure puts you at risk for heart disease and stroke, which are leading causes of death. About 75 million American adults (32%) have high blood pressure—that’s 1 in every 3 adults and high blood pressure was a primary or contributing cause of death for more than 410,000 Americans in 2014—that’s more than 1,100 deaths each day1, 3.

Read More